{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:43:15Z","timestamp":1790239395752,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying single nucleotide polymorphisms (SNPs) that influence chemotherapy disposition may help to personalize cancer treatment and limit toxicity. Genome-wide approaches are unbiased, compared with candidate gene studies, but usually require large cohorts. As most chemotherapy is given cyclically multiple blood sampling is required to adequately define drug disposition, limiting patient recruitment. We found that carboplatin and paclitaxel disposition are stable phenotypes in ovarian cancer patients and tested a genome-wide association study (GWAS) design to identify SNPs associated with chemotherapy disposition. We found highly significant SNPs in <jats:italic>ABCC2<\/jats:italic>, a known carboplatin transporter, associated with carboplatin clearance (asymptotic <jats:italic>P<\/jats:italic>\u2009=\u20095.2\u2009\u00d7\u200910<jats:sup>6<\/jats:sup>, empirical <jats:italic>P<\/jats:italic>\u2009=\u20091.4\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>), indicating biological plausibility. We also identified novel SNPs associated with paclitaxel disposition, including rs17130142 with genome-wide significance (asymptotic <jats:italic>P<\/jats:italic>\u2009=\u20092.0\u2009\u00d7\u200910<jats:sup>\u22129<\/jats:sup>, empirical <jats:italic>P<\/jats:italic>\u2009=\u20091.3\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>). Although requiring further validation, our work demonstrated that GWAS of chemotherapeutic drug disposition can be effective, even in relatively small cohorts, and can be adopted in drug development and treatment programs.<\/jats:p>","DOI":"10.1038\/s41598-018-19590-w","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T11:28:58Z","timestamp":1516274938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"Bo","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Nieuweboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Boere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Joy M.","family":"de Graan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"J. Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoke-Eng","family":"Chiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Johnatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Beale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Luccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H. J.","family":"Mathijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"R. Harnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary L.","family":"Balleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6731-8142","authenticated-orcid":false,"given":"Stuart","family":"Macgregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"de Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"19590_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrclinonc.2014.40","volume":"11","author":"RH Mathijssen","year":"2014","unstructured":"Mathijssen, R. H., Sparreboom, A. & Verweij, J. Determining the optimal dose in the development of anticancer agents. Nat. Rev. Clin. Oncol. 11, 272\u2013281, https:\/\/doi.org\/10.1038\/nrclinonc.2014.40 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"19590_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-03-0060","volume":"10","author":"ME de Jonge","year":"2004","unstructured":"de Jonge, M. E. et al. Bayesian pharmacokinetically guided dosing of paclitaxel in patients with non-small cell lung cancer. Clin. Cancer Res. 10, 2237\u20132244 (2004).","journal-title":"Clin. Cancer Res."},{"key":"19590_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1445-5994.1996.tb01925.x","volume":"26","author":"MJ Millward","year":"1996","unstructured":"Millward, M. J. et al. Carboplatin dosing based on measurement of renal function\u2013experience at the Peter MacCallum Cancer Institute. Aust. N. Z. J. Med. 26, 372\u2013379 (1996).","journal-title":"Aust. N. Z. J. Med."},{"key":"19590_CR4","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols, R. F. et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21, 3194\u20133200, https:\/\/doi.org\/10.1200\/JCO.2003.02.153 (2003).","journal-title":"J Clin Oncol"},{"key":"19590_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnci\/djg036","volume":"95","author":"A du Bois","year":"2003","unstructured":"du Bois, A. et al. A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer. J. Natl. Cancer Inst. 95, 1320\u20131329 (2003).","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl 1","key":"19590_CR6","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","volume":"95","author":"AP Heintz","year":"2006","unstructured":"Heintz, A. P. et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95(Suppl 1), S161\u2013192, https:\/\/doi.org\/10.1016\/S0020-7292(06)60033-7 (2006).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"19590_CR7","first-page":"951","volume":"10","author":"Y Takei","year":"2003","unstructured":"Takei, Y. et al. A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer. Oncol. Rep. 10, 951\u2013955 (2003).","journal-title":"Oncol. Rep."},{"key":"19590_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(09)61157-0","volume":"374","author":"N Katsumata","year":"2009","unstructured":"Katsumata, N. et al. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet 374, 1331\u20131338, https:\/\/doi.org\/10.1016\/S0140-6736(09)61157-0 (2009).","journal-title":"Lancet"},{"key":"19590_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1345\/aph.1C336","volume":"37","author":"BT Yim","year":"2003","unstructured":"Yim, B. T., Sims-McCallum, R. P. & Chong, P. H. Rasburicase for the treatment and prevention of hyperuricemia. Ann. Pharmacother. 37, 1047\u20131054 (2003).","journal-title":"Ann. Pharmacother."},{"key":"19590_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/clpt.2010.320","volume":"89","author":"MV Relling","year":"2011","unstructured":"Relling, M. V. et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin. Pharmacol. Ther. 89, 387\u2013391, https:\/\/doi.org\/10.1038\/clpt.2010.320 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"key":"19590_CR11","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1158\/1078-0432.CCR-06-2290","volume":"13","author":"JF Cote","year":"2007","unstructured":"Cote, J. F. et al. UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan. Clin. Cancer Res. 13, 3269\u20133275, https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2290 (2007).","journal-title":"Clin. Cancer Res."},{"key":"19590_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1742-7843.2008.00351.x","volume":"104","author":"H Green","year":"2009","unstructured":"Green, H. et al. Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer. Basic Clin Pharmacol Toxicol 104, 130\u2013137, https:\/\/doi.org\/10.1111\/j.1742-7843.2008.00351.x (2009).","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"19590_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s002800050822","volume":"42","author":"H Okamoto","year":"1998","unstructured":"Okamoto, H., Nagatomo, A., Kunitoh, H., Kunikane, H. & Watanabe, K. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae. Cancer Chemother. Pharmacol. 42, 307\u2013312 (1998).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"19590_CR14","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1158\/1078-0432.CCR-07-0064","volume":"13","author":"M Joerger","year":"2007","unstructured":"Joerger, M. et al. Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. Clin Cancer Res 13, 6410\u20136418, https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0064 (2007).","journal-title":"Clin Cancer Res"},{"key":"19590_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/oxfordjournals.annonc.a059287","volume":"6","author":"MT Huizing","year":"1995","unstructured":"Huizing, M. T. et al. Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial. Ann. Oncol. 6, 699\u2013704 (1995).","journal-title":"Ann. Oncol."},{"key":"19590_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/JCO.1995.13.1.180","volume":"13","author":"L Gianni","year":"1995","unstructured":"Gianni, L. et al. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic\/pharmacodynamic relationships in humans. J. Clin. Oncol. 13, 180\u2013190 (1995).","journal-title":"J. Clin. Oncol."},{"key":"19590_CR17","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert, A. H. et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J. Clin. Oncol. 7, 1748\u20131756 (1989).","journal-title":"J. Clin. Oncol."},{"key":"19590_CR18","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336\u20132337, https:\/\/doi.org\/10.1093\/bioinformatics\/btq419 (2010).","journal-title":"Bioinformatics"},{"key":"19590_CR19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/sj.emboj.7601637","volume":"26","author":"A Schmidt","year":"2007","unstructured":"Schmidt, A., Durgan, J., Magalhaes, A. & Hall, A. Rho GTPases regulate PRK2\/PKN2 to control entry into mitosis and exit from cytokinesis. EMBO J. 26, 1624\u20131636, https:\/\/doi.org\/10.1038\/sj.emboj.7601637 (2007).","journal-title":"EMBO J."},{"key":"19590_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nature05874","volume":"447","author":"Encode Project Consortium","year":"2007","unstructured":"Encode Project Consortium. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799\u2013816, https:\/\/doi.org\/10.1038\/nature05874 (2007).","journal-title":"Nature"},{"key":"19590_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"Encode Project Consortium","year":"2012","unstructured":"Encode Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374, https:\/\/doi.org\/10.1038\/nature11247 (2012).","journal-title":"Nature"},{"key":"19590_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0005-2736(99)00169-8","volume":"1461","author":"J Konig","year":"1999","unstructured":"Konig, J., Nies, A. T., Cui, Y., Leier, I. & Keppler, D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1461, 377\u2013394 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"19590_CR23","first-page":"787","volume":"378","author":"D Keppler","year":"1997","unstructured":"Keppler, D., Leier, I. & Jedlitschky, G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378, 787\u2013791 (1997).","journal-title":"Biol. Chem."},{"key":"19590_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/A:1016020626941","volume":"18","author":"L Payen","year":"2002","unstructured":"Payen, L. et al. The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol. Toxicol. 18, 221\u2013233 (2002).","journal-title":"Cell Biol. Toxicol."},{"key":"19590_CR25","doi-asserted-by":"publisher","first-page":"55449","DOI":"10.18632\/oncotarget.10961","volume":"7","author":"Z Li","year":"2016","unstructured":"Li, Z. et al. ABCC2-24C> T polymorphism is associated with the response to platinum\/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients. Oncotarget 7, 55449\u201355457, https:\/\/doi.org\/10.18632\/oncotarget.10961 (2016).","journal-title":"Oncotarget"},{"issue":"29\u201337","key":"19590_CR26","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.trsl.2015.12.011","volume":"171","author":"E Rumiato","year":"2016","unstructured":"Rumiato, E. et al. A germline predictive signature of response to platinum chemotherapy in esophageal cancer. Transl Res 171(29\u201337), e21, https:\/\/doi.org\/10.1016\/j.trsl.2015.12.011 (2016).","journal-title":"Transl Res"},{"key":"19590_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40360-015-0001-5","volume":"16","author":"S Lambrechts","year":"2015","unstructured":"Lambrechts, S. et al. Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC Pharmacol Toxicol 16, 2, https:\/\/doi.org\/10.1186\/s40360-015-0001-5 (2015).","journal-title":"BMC Pharmacol Toxicol"},{"key":"19590_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.lungcan.2010.09.001","volume":"72","author":"B Han","year":"2011","unstructured":"Han, B. et al. Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients. Lung Cancer 72, 238\u2013243, https:\/\/doi.org\/10.1016\/j.lungcan.2010.09.001 (2011).","journal-title":"Lung Cancer"},{"key":"19590_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00280-009-1046-1","volume":"65","author":"N Sun","year":"2010","unstructured":"Sun, N. et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 65, 437\u2013446, https:\/\/doi.org\/10.1007\/s00280-009-1046-1 (2010).","journal-title":"Cancer Chemother Pharmacol"},{"key":"19590_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/FPC.0b013e32834d672b","volume":"21","author":"L Elens","year":"2011","unstructured":"Elens, L. et al. Functional defect caused by the 4544G> A SNP in ABCC2: potential impact for drug cellular disposition. Pharmacogenet. Genomics 21, 884\u2013893, https:\/\/doi.org\/10.1097\/FPC.0b013e32834d672b (2011).","journal-title":"Pharmacogenet. Genomics"},{"key":"19590_CR31","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","volume":"112","author":"L Wojnowski","year":"2005","unstructured":"Wojnowski, L. et al. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 112, 3754\u20133762, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.576850 (2005).","journal-title":"Circulation"},{"key":"19590_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bjh.12516","volume":"163","author":"SH Armenian","year":"2013","unstructured":"Armenian, S. H. et al. Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation. Br. J. Haematol. 163, 205\u2013213, https:\/\/doi.org\/10.1111\/bjh.12516 (2013).","journal-title":"Br. J. Haematol."},{"key":"19590_CR33","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1128\/AAC.47.5.1636-1642.2003","volume":"47","author":"K Hidemura","year":"2003","unstructured":"Hidemura, K. et al. Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2. Antimicrob. Agents Chemother. 47, 1636\u20131642 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19590_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrm1946","volume":"7","author":"JA Goodrich","year":"2006","unstructured":"Goodrich, J. A. & Kugel, J. F. Non-coding-RNA regulators of RNA polymerase II transcription. Nat. Rev. Mol. Cell Biol. 7, 612\u2013616, https:\/\/doi.org\/10.1038\/nrm1946 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"19590_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1101\/gad.455708","volume":"22","author":"M Beltran","year":"2008","unstructured":"Beltran, M. et al. A natural antisense transcript regulates Zeb2\/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev. 22, 756\u2013769, https:\/\/doi.org\/10.1101\/gad.455708 (2008).","journal-title":"Genes Dev."},{"key":"19590_CR36","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1126\/science.1117705","volume":"311","author":"T Sanchez-Elsner","year":"2006","unstructured":"Sanchez-Elsner, T., Gou, D., Kremmer, E. & Sauer, F. Noncoding RNAs of trithorax response elements recruit Drosophila Ash1 to Ultrabithorax. Science 311, 1118\u20131123, https:\/\/doi.org\/10.1126\/science.1117705 (2006).","journal-title":"Science"},{"key":"19590_CR37","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly, A. K. et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41, 816\u2013819, https:\/\/doi.org\/10.1038\/ng.379 (2009).","journal-title":"Nat. Genet."},{"key":"19590_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"E Link","year":"2008","unstructured":"Link, E. et al. SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study. N. Engl. J. Med. 359, 789\u2013799, https:\/\/doi.org\/10.1056\/NEJMoa0801936 (2008).","journal-title":"N. Engl. J. Med."},{"key":"19590_CR39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","volume":"364","author":"M McCormack","year":"2011","unstructured":"McCormack, M. et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N. Engl. J. Med. 364, 1134\u20131143, https:\/\/doi.org\/10.1056\/NEJMoa1013297 (2011).","journal-title":"N. Engl. J. Med."},{"key":"19590_CR40","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki, T. et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum. Mol. Genet. 20, 1034\u20131041, https:\/\/doi.org\/10.1093\/hmg\/ddq537 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"19590_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nbt.2424","volume":"30","author":"AR Harper","year":"2012","unstructured":"Harper, A. R. & Topol, E. J. Pharmacogenomics in clinical practice and drug development. Nat. Biotechnol. 30, 1117\u20131124, https:\/\/doi.org\/10.1038\/nbt.2424 (2012).","journal-title":"Nat. Biotechnol."},{"key":"19590_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1634\/theoncologist.3-1-15","volume":"3","author":"DS Alberts","year":"1998","unstructured":"Alberts, D. S. & Dorr, R. T. New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors. Oncologist 3, 15\u201334 (1998).","journal-title":"Oncologist"},{"key":"19590_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft, D. W. & Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31\u201341 (1976).","journal-title":"Nephron"},{"key":"19590_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0378-4347(97)00502-1","volume":"705","author":"A Sparreboom","year":"1998","unstructured":"Sparreboom, A. et al. Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B Biomed. Sci. Appl. 705, 159\u2013164 (1998).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"19590_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1039\/C2AY05182F","volume":"4","author":"H Louie","year":"2012","unstructured":"Louie, H., Wong, C., Huang, Y. J. & Fredrickson, S. A study of techniques for the preservation of mercury and other trace elements in water for analysis by inductively coupled plasma mass spectrometry (ICP-MS). Anal Methods 4, 522\u2013529 (2012).","journal-title":"Anal Methods"},{"key":"19590_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2125.2003.01826.x","volume":"56","author":"S Callies","year":"2003","unstructured":"Callies, S. et al. A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979). Br. J. Clin. Pharmacol. 56, 46\u201356 (2003).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"19590_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575, https:\/\/doi.org\/10.1086\/519795 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"19590_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904\u2013909, https:\/\/doi.org\/10.1038\/ng1847 (2006).","journal-title":"Nat. Genet."},{"key":"19590_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol, A. D., Scott, L. J., Abecasis, G. R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209\u2013213, https:\/\/doi.org\/10.1038\/ng1706 (2006).","journal-title":"Nat. Genet."},{"key":"19590_CR50","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191, https:\/\/doi.org\/10.1093\/bioinformatics\/btq340 (2010).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19590-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19590-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19590-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:31:03Z","timestamp":1671586263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19590-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19590-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,24]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1508"}}